Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14) Peptid
TNFRSF14
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle HVEM (TNFRSF14) Produkte
- HVEM (TNFRSF14) (Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- HVEM peptide corresponds to 12 amino acids of HVEM.
-
-
- Applikationshinweise
- HVEM Peptide is used for blocking the activity of HVEM antibody . The HVEM antibody ships at 0.5 mg/mL and the HVEM Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- HVEM peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- HVEM (TNFRSF14) (Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))
- Synonyme
- ATAR Peptide, CD270 Peptide, HVEA Peptide, HVEM Peptide, LIGHTR Peptide, TR2 Peptide, Atar Peptide, HveA Peptide, Hvem Peptide, Tnfrs14 Peptide, TNF receptor superfamily member 14 Peptide, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) Peptide, Tnfrsf14 Peptide, TNFRSF14 Peptide
- Substanzklasse
- Viral Protein
- Gen-ID
- 8764
- NCBI Accession
- NP_003811
- OMIM
- 23200041
- UniProt
- Q92956
-
Sie sind hier:
